PharmaBoardroom

Interview with Eduardo Macchiavello, CEO, Roemmers

Roemmers fue establecida en 1921. ¿Cómo paso de ser una empresa familiar a la empresa que es hoy, y cuáles han sido los desafíos en el cambio en…

Interview with Samuel Mauricio, Vice President and General…

Mr. Mauricio, you’ve mentioned that Brazil is a different kind of market for Octapharma, one strongly based on price, and that because of this…

Interview with Guillaume DRIANNO, General Manager, Servier Brasil

When we met Servier Brazil five years ago the company had major ambitions: ‘grow more than 10% for the five following years’. How have these…

Interview with Jim Harold, CPO Head and Country President,…

When we met with Javier Lombar at IMS Argentina, he was explaining how a lot of multinational companies are using Argentina as a regional base of…

Interview with Pawel Sztwiertnia, General Director, INFARMA

Until very recently originator drugs had a very weak presence in central and east European countries including Poland, and there was no real patent…

Interview with Mohammad Shahin, Chairman & CEO, JOSWE

With forty years of experience behind your belt, you founded JOSWE in 2000. What were the opportunities in the market that you saw to establish the…

Interview with Emil Zörner, Executive Director, Česká…

Dr. Zörner, can you please begin by introducing our readers to the CAFF (Czech Association of Pharmaceutical Firms), and explicate its key activities…

Thailand: Survival of the Fittest in the Land of Smiles

Indochina's biggest pharmaceutical market (US$ 4 billion, 66 million population, Indochina's biggest pharmaceutical market (US$ 4 billion, 66 million…